Wild type NRAS
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HC (1) | Wild type KRAS, Wild type NRAS | Colorectal Adenocarcinoma | Panitumumab | |
| FDA (1) | HER2-positive, Wild type KRAS, Wild type NRAS | Colorectal Adenocarcinoma | Trastuzumab, Tucatinib |